Stocks · Health care · Pharmaceutical Preparations

Korro Bio, Inc.

KRRO Clue Score32
United States Fiscal year ends December CIK 0001703647 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Lynx1 Capital Management LP
26 Oct 2026
10% owner
Buy indirect
25,124
$11.75
$295.09K
Lynx1 Capital Management LP
23 Oct 2026
10% owner
Buy indirect
2,510
$12.11
$30.39K
Lynx1 Capital Management LP
22 Oct 2026
10% owner
Buy indirect
40,000
$11.04
$441.46K
Lynx1 Capital Management LP
22 Oct 2026
10% owner
Buy indirect
12,175
$9.68
$117.81K

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 2 Oct 2019